Applied Nutrition expands range for weight loss treatment users

Health and wellness brand focuses on customers using GLP-1 treatments after surge in demand

Applied Nutrition says it is expanding its portfolio of products for customers using weight loss medications following a spike in demand over the past year.

The health and wellness brand said the dramatic rise in Britons using GLP-1 treatments, such as Mounjaro and Wegovy, has created an opportunity to launch products specifically tailored for these consumers. Those new products will launch later this year.

The Merseyside firm has already entered the sector, offering GLP-1-compatible high-protein ready meals from the end of last year. Thomas Ryder, founder and chief executive of the company, stated the business believes it can benefit long-term from serving customers using weight-loss treatments.

He told the Press Association news agency: “The GLP-1 user is a growing customer.

“We see this as a consumer at the start of their weight loss journey who is now looking at how the medication can help them.

“There is an opportunity, as those customers often need supplements and need smaller portions.

“I think this is a catalyst for the health and wellness space if we have that consumer in mind.

“We do have a number of products we will bring to market in this area because we do see that area growing.”

Mr Ryder said the company has seen growth after pursuing new customer opportunities and channel diversification, which has witnessed the business expand in UK retail outlets. Last month, the business reported stronger sales and profits for the previous year.

The London-listed firm said pre-tax profits surged by 77.1% to £20.9 million for the six months to 31 January, compared with the prior year. Applied Nutrition said this followed a 56.5% rise in sales to £74.5 million for the half-year period.

However, it also warned that sales volumes in the Middle East are expected to be affected by the ongoing conflict in the region.